Anesthesia & Pain Management Sponsored by Pacira Pharmaceuticals
ADA, CDC webinar summarizes dentists' role in opioid crisis
February 16, 2018 -- Two pain management experts discussed the role of dentists in the opioid crisis during a February 14 webinar jointly hosted by the ADA and the U.S. Centers for Disease Control and Prevention (CDC). The webinar focused on the best strategies to manage acute pain and prevent opioid misuse and abuse.  Discuss
The over-the-counter opioid epidemic?
February 8, 2018 -- Most of the attention about the opioid epidemic focuses on the abuse of prescription drugs, but pharmacist Tom Viola notes that over-the-counter products also can contribute to the issue. He details how a popular treatment for diarrhea may contribute to opioid abuse and also influence how you treat certain patients.  Discuss
Study: Dentists prescribe only 2% of opioids
CE
January 26, 2018 -- The amount of opioids prescribed by all healthcare practitioners in the U.S. has increased over the last 15 years, but the total quantity of opioids prescribed by dentists has declined, according to a new study. As of 2012, dental professionals prescribed only about 2% of the total quantity of opioids.
 Discuss
Trump officially declares opioid epidemic an emergency
October 26, 2017 -- U.S. President Donald Trump has officially declared the opioid epidemic a public health emergency, garnering praise from the ADA.
FDA expands the opioids covered by risk mitigation strategy
September 29, 2017 -- So-called "immediate-release" opioid pain medications will now be subject to more stringent requirements by the U.S. Food and Drug Administration (FDA) to help stem the tide of opioid misuse and abuse, according to a statement from FDA Director Scott Gottlieb, MD.  Discuss
New white paper offers opioid use recommendations
August 29, 2017 -- A new white paper from the American Association of Oral and Maxillofacial Surgeons recommends that ibuprofen, not opioids, be used as a first-line therapy for managing a patient's acute and postsurgical pain.  Discuss
Opioid analgesic Opana ER pulled from U.S. market
July 6, 2017 -- Endo Pharmaceuticals has announced it will voluntarily remove its opioid analgesic Opana ER from the U.S. market because of a risk for abuse.  Discuss
Second Opinion: Outpatient detoxification for opioid-addicted patients
June 15, 2017 -- While steps are needed to reduce the number of prescribed opioids in the U.S., what about those patients who may already be addicted and at risk? In this Second Opinion, Vikram Tarugu, MD, details a detoxification program that may be appropriate for your patients and your community.  Discuss
FDA asks drug firm to stop selling opioid analgesic Opana ER
June 9, 2017 -- The U.S. Food and Drug Administration (FDA) has requested that Endo Pharmaceuticals stop selling the reformulated version of its opioid analgesic Opana ER due to the risk for abuse.  Discuss
Opioid painkillers more common in low-income households
CE
May 26, 2017 -- Household income may determine whether a patient uses an opioid or nonopioid analgesic for dental pain, a new study has found. Participants from households making less than $15,000 per year were nearly twice as likely to take opioids than those from the highest income bracket.
 Discuss
Hot Topic
Second Opinion: Outpatient detoxification for opioid-addicted patients

While steps are needed to reduce the number of prescribed opioids in the U.S., what about those patients who may already be addicted and at risk? In this Second Opinion, Vikram Tarugu, MD, details a detoxification program that may be appropriate for your patients and your community. Read more.

Conferences
IV Moderate Sedation Training
March 2-18
Charlotte, North Carolina United States
ACLS for Dentists and Staff -- Medical Emergency Training
March 9
Charlotte, North Carolina United States
IV Moderate Sedation Training
April 6-22
Seattle, Washington United States
ACLS for Dentists and Staff -- Medical Emergency Training
April 13
Seattle, Washington United States